137 related articles for article (PubMed ID: 24709317)
1. [Deep vein thrombosis revealing myeloproliferative syndrome in two adolescents].
Bertrand A; Heissat S; Caron N; Viremouneix L; Pracros JP; Javouhey E; Lachaux A; Mialou V
Arch Pediatr; 2014 May; 21(5):497-500. PubMed ID: 24709317
[TBL] [Abstract][Full Text] [Related]
2. JAK2 V617F-positive latent essential thrombocythemia and splanchnic vein thrombosis: the role of bone marrow biopsy for the diagnosis of myeloproliferative disease.
Allegra A; Alonci A; Penna G; D'Angelo A; Rizzotti P; Granata A; Musolino C
Acta Haematol; 2009; 121(4):218-20. PubMed ID: 19478480
[TBL] [Abstract][Full Text] [Related]
3. [Budd-Chiari syndrome and splanchnic vein thrombosis: masked myeloproliferative neoplasms and JAK2V617F].
Fama A; Rago A; Gioiosa F; Marzano C; Latagliata R; Mammì C; Laganà C; D'Elia GM; Bizzoni L; Trasarti S; Ferretti A; Breccia M; Riggio O; Tafuri A
Clin Ter; 2010; 161(2):169-71. PubMed ID: 20499034
[TBL] [Abstract][Full Text] [Related]
4. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis.
Primignani M; Barosi G; Bergamaschi G; Gianelli U; Fabris F; Reati R; Dell'Era A; Bucciarelli P; Mannucci PM
Hepatology; 2006 Dec; 44(6):1528-34. PubMed ID: 17133457
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis.
De Stefano V; Teofili L; Leone G; Michiels JJ
Semin Thromb Hemost; 1997; 23(5):411-8. PubMed ID: 9387199
[TBL] [Abstract][Full Text] [Related]
6. Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms.
Fiorini A; Chiusolo P; Rossi E; Za T; De Ritis DG; Ciminello A; Leone G; De Stefano V
Am J Hematol; 2009 Feb; 84(2):126-7. PubMed ID: 19105231
[No Abstract] [Full Text] [Related]
7. JAK2(V617F) positive early stage myeloproliferative disease (essential thrombocythemia) as the cause of portal vein thrombosis in two middle-aged women: therapeutic implications in view of the literature.
Michiels JJ; Commandeur S; Hoogenboom GJ; Wegman JJ; Scholten L; van Rijssel RH; De Raeve H
Ann Hematol; 2007 Nov; 86(11):793-800. PubMed ID: 17687555
[TBL] [Abstract][Full Text] [Related]
8. [Portal vein thrombosis as the main symptom of unclassified JAK2-positive myeloproliferative neoplasm--case report].
Karakulska-Prystupiuk E; Gierej B; Paszkowska-Kowalewska M; Wilkowojska U; Jedrzejczak WW
Pol Merkur Lekarski; 2012 Jul; 33(193):29-31. PubMed ID: 22993907
[TBL] [Abstract][Full Text] [Related]
9. Budd-Chiari syndrome and portal vein thrombosis due to essential thrombocytosis.
Coban S; Ertugrul I; Ekiz F; Akif Teber M; Yuksel O
Platelets; 2010; 21(2):144-6. PubMed ID: 20085436
[TBL] [Abstract][Full Text] [Related]
10. Undiagnosed myeloproliferative disease in cases of intra-abdominal thrombosis: the utility of the JAK2 617F mutation.
P'ng S; Carnley B; Baker R; Kontorinis N; Cheng W
Clin Gastroenterol Hepatol; 2008 Apr; 6(4):472-5. PubMed ID: 18328792
[TBL] [Abstract][Full Text] [Related]
11. Budd-Chiari syndrome and portal vein thrombosis associated with myeloproliferative disorders: diagnosis and management.
Brière JB
Semin Thromb Hemost; 2006 Apr; 32(3):208-18. PubMed ID: 16673275
[TBL] [Abstract][Full Text] [Related]
12. JAK2 mutations across a spectrum of venous thrombosis cases.
Shetty S; Kulkarni B; Pai N; Mukundan P; Kasatkar P; Ghosh K
Am J Clin Pathol; 2010 Jul; 134(1):82-5. PubMed ID: 20551270
[TBL] [Abstract][Full Text] [Related]
13. JAK2V617F mutation in patients with splanchnic vein thrombosis.
Xavier SG; Gadelha T; Pimenta G; Eugenio AM; Ribeiro DD; Gomes FM; Bonamino M; Zalcberg IR; Spector N
Dig Dis Sci; 2010 Jun; 55(6):1770-7. PubMed ID: 19690956
[TBL] [Abstract][Full Text] [Related]
14. Multiple thrombophilic factors in a patient with Budd-Chiari syndrome.
Brancaccio V; Iannaccone L; Margaglione M; Guardascione MA; Amitrano L
Clin Lab Haematol; 2002 Feb; 24(1):61-3. PubMed ID: 11843901
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of JAK29V617F) mutation in intra-abdominal venous thrombosis.
Deepak A; Punamiya S; Patel N; Parekh S; Mehta S; Shah N
Trop Gastroenterol; 2011; 32(4):279-84. PubMed ID: 22696908
[TBL] [Abstract][Full Text] [Related]
16. [JAK2 mutation and thrombosis - recommendations for screening].
Linnemann B; Lindhoff-Last E
Dtsch Med Wochenschr; 2011 Dec; 136(48):2454-7. PubMed ID: 22109574
[No Abstract] [Full Text] [Related]
17. JAK2 mutation-negative essential thrombocythemia in a child presenting with cerebral venous thrombosis.
Khan AA; Kumar V; Anand I; Kumar M; Sharma P; Bhargava M
Hematol Oncol Stem Cell Ther; 2012; 5(1):66-8. PubMed ID: 22446615
[TBL] [Abstract][Full Text] [Related]
18. JAK2 V617F mutation, mesenteric vein thrombosis, and myeloproliferative disorders.
Owens CD
J Vasc Surg; 2010 Jul; 52(1):205-7. PubMed ID: 20434300
[TBL] [Abstract][Full Text] [Related]
19. Budd-Chiari syndrome associated with factor V leiden mutation: a report of 6 patients.
Hoffman R; Nimer A; Lanir N; Brenner B; Baruch Y
Liver Transpl Surg; 1999 Mar; 5(2):96-100. PubMed ID: 10071347
[TBL] [Abstract][Full Text] [Related]
20. Abdominal thromboses of splanchnic, renal and ovarian veins.
De Stefano V; Martinelli I
Best Pract Res Clin Haematol; 2012 Sep; 25(3):253-64. PubMed ID: 22959542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
